196 filings
Page 5 of 10
8-K
taji2ox x8090wj9
3 Aug 21
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results
4:07pm
8-K
5aahjng 7kme890l2
25 Jun 21
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
qxkvjpz czizh3ww2p8o
4 May 21
Deciphera Pharmaceuticals, Inc. Announces First Quarter 2021 Financial Results
4:16pm
DEFA14A
krey vgwii6w4pqo3rv
29 Apr 21
Additional proxy soliciting materials
4:08pm
8-K
ie212k 0v8tr7ohvj
31 Mar 21
China NMPA approval follows 2020 U.S. FDA approval for the treatment of patients with fourth-line GIST
7:54am
S-8
b7xmpxxd
9 Feb 21
Registration of securities for employees
4:52pm
8-K
plkjayp7kr
9 Feb 21
Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
mwfg2q
11 Jan 21
Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones
7:15am
8-K
qdyzt z0sp4
30 Nov 20
Regulation FD Disclosure
7:12am
8-K
ibhgargy64wg3qko0pa
12 Nov 20
Other Events
7:30am
8-K
8wv dzps2m8g
5 Nov 20
Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results
4:10pm
8-K
zoqbdqwyngpu e5oi5
4 Aug 20
Entry into a Material Definitive Agreement
5:11pm
424B5
bwdo0we v5
4 Aug 20
Prospectus supplement for primary offering
5:06pm
8-K
vz1fijn7
4 Aug 20
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2020 Financial Results
4:08pm
8-K
2kgh ds2b1
12 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:06pm